Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection

Abstract Background Efficacy and safety of long-acting cabotegravir (CAB) + rilpivirine (RPV) every 8 weeks (Q8W) versus daily oral standard of care (SoC) maintenance in treatment-experienced individuals with virologically suppressed human immunodeficiency virus type 1 (HIV-1) has not been directly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vasiliki Chounta, Sonya J. Snedecor, Sterling Wu, Nicolas Van de Velde
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-05-01
Colecção:BMC Infectious Diseases
Assuntos:
Anti-HIV agents/administration and dosage
Anti-retroviral agents/therapeutic use
HIV infections/drug therapy
Indirect treatment comparison
Long-acting
Acesso em linha:https://doi.org/10.1186/s12879-022-07243-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados